A Multicenter Retrospective Study of Mogamulizumab Efficacy in Adult T-Cell Leukemia/Lymphoma

Clinical Lymphoma, Myeloma and Leukemia

Volumn 17, Issue 1, 2017, Pages 23-30.e2

  Iyama, Satoshi ^a   Sato, Tsutomu ^a   Ohnishi, Hirofumi ^a   Kanisawa, Yuji ^b   Ohta, Shuichi ^c   Kondo, Takeshi ^d   Mori, Akio ^e   Tsutsumi, Yutaka ^f   Kuroda, Hiroyuki ^g   Kakinoki, Yasutaka ^h   Yamamoto, Satoshi ⁱ   Takahashi, Tohru ^j   Shindo, Motohiro ^k   Torimoto, Yoshihiro ^k   Sato, Kazuya ^l   Iwasaki, Hiroshi ^m   Haseyama, Yoshihito ⁿ   Kohda, Kyuhei ^o   Nagamachi, Yasuhiro ^p   Hirayama, Yasuo ^q   Sakai, Hajime ^r   Hirata, Yasuji ^s   Fukuhara, Takashi ^m   Ikeda, Hiroshi ^a   Kobune, Masayoshi ^a   Kato, Junji ^a   Kurosawa, Mitsutoshi ^t   more..

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Oji General Hospital   (Japan)

^c SAPPORO HOKUYU HOSPITAL   (Japan)

^d HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e Department of Internal Medicine Aiiku Hospital   (Japan)

^f Hakodate Municipal Hospital   (Japan)

^g Steel Memorial Muroran Hospital   (Japan)

^h Asahikawa City Hospital   (Japan)

ⁱ SAPPORO CITY GENERAL HOSPITAL   (Japan)

^j Tenshi Hospital   (Japan)

^k ASAHIKAWA MEDICAL COLLEGE   (Japan)

^l Department of Gastroenterology   (Japan)

^m Sapporo Kosei General Hospital   (Japan)

ⁿ Tonan Hospital   (Japan)

^o ASAHIKAWA RED CROSS HOSPITAL   (Japan)

^p Sapporo Kiyota Hospital   (Japan)

^q Higashi Sapporo Hospital   (Japan)

^r TEINE KEIJINKAI HOSPITAL   (Japan)

^s Hakodate Red Cross Hospital   (Japan)

^t HOKKAIDO CANCER CENTER   (Japan)

more..

Author keywords

ATL; CCR4; GVHD; Mogamulizumab; Treg

Indexed keywords

CALCIUM; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; LACTATE DEHYDROGENASE; MOGAMULIZUMAB; PREDNISONE; RANIMUSTINE; SOLUBLE INTERLEUKIN 2 RECEPTOR; VINCRISTINE; VINDESINE; MONOCLONAL ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; DRUG EFFICACY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; RETROSPECTIVE STUDY; SALVAGE THERAPY; SURVIVAL RATE; T CELL LEUKEMIA; VERY ELDERLY; CLINICAL TRIAL; GRAFT VERSUS HOST REACTION; JAPAN; MIDDLE AGED; PROCEDURES;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL, HUMANIZED; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; JAPAN; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84992313472     PISSN: 21522650     EISSN: 21522669     Source Type: Journal    
DOI: 10.1016/j.clml.2016.09.009     Document Type: Article

References (29)

1. 1 Uchiyama, T., Yodoi, J., Sagawa, K., Takatsuki, K., Uchino, H., Adult T-cell leukemia: Clinical and hematologic features of 16 cases. Blood 50 (1977), 481–492.
2. 2 Yoshida, M., Seiki, M., Yamaguchi, K., Takatsuki, K., Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci U S A 81 (1984), 2534–2537.
3. 3 Fukushima, T., Nomura, S., Shimoyama, M., et al. Japan Clinical Oncology Group (JCOG) prognostic index and characterization of long-term survivors of aggressive adult T-cell leukaemia-lymphoma (JCOG0902A). Br J Haematol 166 (2014), 739–748.
4. 4 Ishitsuka, K., Tamura, K., Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma. Lancet Oncol 15 (2014), e517–e526.
5. 5 Utsunomiya, A., Choi, I., Chihara, D., Seto, M., Recent advances in the treatment of adult T-cell leukemia-lymphomas. Cancer Sci 106 (2015), 344–351.
6. 6 Shimoyama, M., Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma: a report from the Lymphoma Study Group (1984-87). Br J Haematol 79 (1991), 428–437.
7. 7 Tsukasaki, K., Utsunomiya, A., Fukuda, H., et al. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol 25 (2007), 5458–5464.
8. 8 Ishida, T., Utsunomiya, A., Iida, S., et al. Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma: its close association with skin involvement and unfavorable outcome. Clin Cancer Res 9:10 Pt 1 (2003), 3625–3634.
9. 9 Ishida, T., Joh, T., Uike, N., et al. Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study. J Clin Oncol 30 (2012), 837–842.
10. 10 Ito, Y., Miyamoto, T., Chong, Y., et al. Successful treatment with anti-CC chemokine receptor 4 MoAb of relapsed adult T-cell leukemia/lymphoma after umbilical cord blood transplantation. Bone Marrow Transplant 48 (2013), 998–999.
11. 11 Uchimaru, K., Nakamura, Y., Tojo, A., Watanabe, T., Yamaguchi, K., Factors predisposing to HTLV-1 infection in residents of the greater Tokyo area. Int J Hematol 88 (2008), 565–570.
12. 12 Satake, M., Yamaguchi, K., Tadokoro, K., Current prevalence of HTLV-1 in Japan as determined by screening of blood donors. J Med Virol 84 (2012), 327–335.
13. 13 Tsukasaki, K., Hermine, O., Bazarbachi, A., et al. Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. J Clin Oncol 27 (2009), 453–459.
14. 14 Gordon, L., Olshen, R.A., Tree-structured survival analysis. Cancer Treat Rep 69 (1985), 1065–1069.
15. 15 Ishitsuka, K., Tamura, K., Treatment of adult T-cell leukemia/lymphoma: past, present, and future. Eur J Haematol 80 (2008), 185–196.
16. 16 Major prognostic factors of patients with adult T-cell leukemia-lymphoma: a cooperative study. Lymphoma Study Group (1984-1987). Leuk Res 15 (1991), 81–90.
17. 17 Yamada, Y., Tomonaga, M., Fukuda, H., et al. A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br J Haematol 113 (2001), 375–382.
18. 18 Ishida, T., Jo, T., Takemoto, S., et al. Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study. Br J Haematol 169 (2015), 672–682.
19. 19 Hishizawa, M., Kanda, J., Utsunomiya, A., et al. Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study. Blood 116 (2010), 1369–1376.
20. 20 Ishida, T., Hishizawa, M., Kato, K., et al. Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma with special emphasis on preconditioning regimen: a nationwide retrospective study. Blood 120 (2012), 1734–1741.
21. 21 Shigematsu, A., Kobayashi, N., Yasui, H., et al. High level of serum soluble interleukin-2 receptor at transplantation predicts poor outcome of allogeneic stem cell transplantation for adult T cell leukemia. Biol Blood Marrow Transplant 20 (2014), 801–805.
22. 22 Fuji, S., Fujiwara, H., Nakano, N., et al. Early application of related SCT might improve clinical outcome in adult T-cell leukemia/lymphoma. Bone Marrow Transplant 51 (2016), 205–211.
23. 23 Sakaguchi, S., Yamaguchi, T., Nomura, T., Ono, M., Regulatory T cells and immune tolerance. Cell 133 (2008), 775–787.
24. 24 Koreth, J., Matsuoka, K., Kim, H.T., et al. Interleukin-2 and regulatory T cells in graft-versus-host disease. N Engl J Med 365 (2011), 2055–2066.
25. 25 Shin, H.J., Baker, J., Leveson-Gower, D.B., Smith, A.T., Sega, E.I., Negrin, R.S., Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells. Blood 118 (2011), 2342–2350.
26. 26 Hashimoto, A., Iyama, S., Sato, T., et al. A case of associated refractory acute graft-versus-host disease following umbilical cord blood transplantation in an adult T-cell leukemia/lymphoma patient pretreated with mogamulizumab. J Hematopoietic Cell Transpl 4 (2015), 52–56.
27. 27 Sugio, T., Kato, K., Aoki, T., et al. Mogamulizumab treatment prior to allogeneic hematopoietic stem cell transplantation induces severe acute graft-versus-host disease. Biol Blood Marrow Transplant 22 (2016), 1608–1614.
28. 28 Inoue, Y., Fuji, S., Tanosaki, R., Fukuda, T., Pretransplant mogamulizumab against ATLL might increase the risk of acute GVHD and non-relapse mortality. Bone Marrow Transplant 51 (2016), 725–727.
29. 29 Haji, S., Kiyasu, J., Choi, I., et al. Administration of an anti-CC chemokine receptor 4 monoclonal antibody, mogamulizumab, before allogeneic bone marrow transplantation for adult T-cell leukemia/lymphoma. Bone Marrow Transplant 51 (2016), 432–434.